This post is mostly a story about a very well manufactured,
safe and effective, foreign
version of an FDA-approved drug. These drugs are normally far less
expensive than the FDA-approved version sold in the U.S. and arguably just as
safe. The FDA can prevent the importation of such drugs – but the agency
is actually encouraged by law not to do so if the import is for personal
use only. It’s also a story about consumers and their providers navigating
conflicting public information about buying less expensive medicines online
from foreign countries.
A friend of mine, who has very difficult to control
cholesterol, was prescribed Livalo, an FDA-approved brand of the drug pitavastatin.
Let’s call him John. With his insurance, Livalo still costs John about $310 for
a three-month supply – about 90 pills. He doesn’t want to pay that much if he
can help it. John knows about our company, PharmacyChecker. He went to our site
to discover that brand-name Livalo (pitavastatin)
costs only $90 for a three-month supply at the lowest-cost
PharmacyChecker-accredited international online pharmacy: a savings of 71%. That
wasn’t enough to convince John to move forward with the purchase. Why not? That
brand-name pitavastatin, sold in Turkey, is sold under the name Alipza –
(more…)Tagged with: Alipza, livalo
Canada believes it is too small to facilitate U.S. wholesale importation of lower-cost drugs. This post will explore a much greater potential for importation from the European Union.
Americans buying less expensive drugs from overseas pharmacies (i.e. personal
importation) often rely on the common belief that the U.S. Food and Drug
Administration exemplifies the “gold standard” in drug safety. This “gold standard”
importation talking point from the
Pharmaceutical and Researchers of America (PhRMA) fuels Americans’ fear of ordering medication
internationally despite proof that importation can be very safe and provide
financial relief and better adherence to prescriptions:
“The United States is the gold standard when it comes to regulating the safety of our medicine supply. Importing medicines from countries that do not have our same strong standards could taint our medicine supply.”
The first sentence
is something you are supposed to take at face value. The second sentence is
deceptively broad: as in, yes, importing medicines from countries that do not
have our “same” standards could taint our medicine supply. Not
necessarily, but it could.
(more…)Tagged with: Katherine Eban
A lot of media coverage about counterfeit drug threats in the U.S. are spurred by the media relations efforts of organizations funded by pharmaceutical companies, such as the Alliance for Safe Online Pharmacies and Partnership for Safe Medicines. As I see it, their public education efforts conflate safe online sales of medicines imported by consumers in the U.S. with counterfeit drug sales and other forms of drug sales, ones that clearly harm patients. One such article that did not fall prey to the propaganda was published in Kaiser Health News’ California Healthline detailing street market sales of prescription drugs, including cases that involve counterfeit drugs and the dangers they pose. Journalists who are looking closely, checking the funding of organizations disseminating information about prescription drug importation, can help stop the propaganda of the pharmaceutical industry.
The Kaiser story, written by John M. Glionna, focuses on
Latino immigrant communities in which people can’t afford medication or, due to
their immigration status, are fearful of deportation if they go to federally-funded
clinics for medical treatments. Eight people were arrested and charged with
illegal street sales of prescription drugs, including injectables and
controlled drugs. Glionna describes the LA County authorities report:
(more…)Tagged with: Immigration, John M. Glionna, kaiser health news, Spanish
“Dispense as Written” are the words found on prescriptions in the U.S. when the prescriber wants the patient to take the brand drug, not the generic. Many who read Katherine Eban’s new book – Bottle of Lies: The Inside Story of the Generic Drug Boom – will conclude that they would like to see “DAW” on their prescriptions.
Bottle of Lies teaches its readers that generic drugs are not as good as the FDA claims. It shows that poor manufacturing practices, mostly in India and China, but also in the U.S., are the leading cause of substandard drugs being sold in U.S. pharmacies and throughout the world. More ominously, India and China intentionally ship even lower quality and, in some cases, worthless drugs to poor countries in Africa and Southeast Asia where regulations are weak or non-existent.
(more…)Tagged with: Bottle of Lies, generics, Katherine Eban
Over 700,000 people died in the U.S. from a drug overdose between 1999 to 2017. That’s about 130 American deaths daily. At PharmacyChecker, we are dedicated to helping fight this epidemic by learning more about the crisis and spreading awareness. I recently obtained certification for The Opioid Crisis in America course offered by Harvard University.
According to a report published by the Substance Abuse and Mental Health Services Administration (SAMHSA), the main channels that people obtain opioid drugs illegally are from a friend or relative for free; buying from a friend or relative; or buying from a drug dealer or stranger.
As our main focus is often online pharmacy and importation, it’s notable that Harvard did not identify online pharmacy or importation as contributors to the opioid epidemic.
(more…)Tagged with: Harvard, opioids, SAMHSA
In their opposition to drug importation legislation, the myriad “non-profit” groups funded by drug companies often cynically invoke the evils of counterfeit drugs. We’ve seen this as recently as this week, when an importation bill triumphantly passed in Florida (Prescription Drug Importation Programs HB19). One such group, the Partnership for Safe Medicines, was called out by PolitiFact for essentially lying that the new state law would “allow” imports from China “without FDA inspection,” tacking on that “too many have already died from counterfeit drugs.”
The Florida drug importation bill builds in so many
regulatory checks that it may in fact make importation from Canada into Florida
safer than our “regular” drug supply chain, but that’s for another post. As it
happens, no one has ever been reported killed by a non-controlled prescription
drug imported from a pharmacy that required a valid prescription.
PolitiFact is right to call out PSM, but I’m sad to report
that, yes, there is a very real counterfeit drug problem in the United States.
But, unlike the fake counterfeit drug facts propagated by groups like PSM to
scare people away from buying lower-cost medicines online, it comes in the form
of illegal fentanyl ingredients used
to make counterfeit prescription narcotics.
(more…)Tagged with: Counterfeit Drugs, opioids, pill presses